Business Description
Daroupakhsh Pharmaceutical Mfg
ISIN : IRO1DPAK0004
Description
Daroupakhsh Pharmaceutical Mfg is a pharmaceutical company based in Iran. It is engaged in developing and manufacturing a wide range of medical therapeutics including infertility, cardiology, diabetology, and neurology. It offers drugs in the form of tablet, injection, capsule, powder, ointment, gel, and syrup. Products offered by the company include Acetaminophen, Diazoxide, Galsulfase, Ketorolac, Isotretinoin, Mupirocin, Risperidone, Sulfasalazine, Tacrolimus, among others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 18.64 | |||||
| 12-1 Month Momentum % | 18.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 12.39 | |||||
| Forward Dividend Yield % | 12.39 | |||||
| 5-Year Yield-on-Cost % | 12.39 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daroupakhsh Pharmaceutical Mfg Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil IRR) | |||
| EPS (TTM) (IRR) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (IRR) | 395.161129 | ||
| 20-Day SMA (IRR) | 0 | ||
| 12-1 Month Momentum % | 18.55 | ||
| 52-Week Range (IRR) | 13420 - 21627.254206 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daroupakhsh Pharmaceutical Mfg Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daroupakhsh Pharmaceutical Mfg Stock Events
| Event | Date | Price(IRR) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daroupakhsh Pharmaceutical Mfg Frequently Asked Questions
What is Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1)'s stock price today?
The current price of XTEH:DPAK1 is IRR13680.00. The 52 week high of XTEH:DPAK1 is IRR21627.25 and 52 week low is IRR13420.00.
When is next earnings date of Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1)?
The next earnings date of Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1) is .
Does Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1) pay dividends? If so, how much?
The Dividend Yield %  of Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1) is 12.39% (As of Today), Highest Dividend Payout Ratio of Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Daroupakhsh Pharmaceutical Mfg(XTEH:DPAK1) is 12.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers